Back to results
US 2024/0094220 A1Published application
Engineering bacillus subtilis as a versatile and stable platform for production of nanobodies
AssigneeNortheastern University
InventorJiahe Li
Life of this patent
Estimating the term…
Abstract
Provided are methods and pharmaceutical compositions related to nanobodies from engineered Bacillus subtilis bacteria which can be useful as therapeutic agents or for diagnostic testing.
Claims142
A nanobody comprising a variable domain of an antibody, wherein the nanobody is contained within a Bacillus subtilis bacteria strain.
Dependencies are inferred from the claim text.